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DObjective: Recently we suggested a comprehensive blood-sparing approach in pediatric cardiac surgery that
resulted in no transfusion in 71 infants (25%), postoperative transfusion only in 68 (24%), and intraoperative
transfusion in 149 (52%). We analyzed the effects of transfusion on postoperative morbidity and mortality in the
same cohort of patients.
Methods: The effect of transfusion on the length of mechanical ventilation and intensive care unit stay was as-
sessed using Kaplan-Meier curves. To assess whether transfusion independently determined the length of me-
chanical ventilation and length of intensive care unit stay, a multivariate model was applied. Additionally, in the
subgroup of transfused infants, the effect of the applied volume of packed red blood cells was assessed.
Results: The median length of mechanical ventilation was 11 hours (interquartile range, 9-18 hours), 33 hours
(interquartile range, 18-80 hours), and 93 hours (interquartile range, 34-161 hours) in the no transfusion, post-
operative transfusion only, and intraoperative transfusion groups, respectively (P<.00001). The corresponding
median lengths of intensive care unit stay were 1 day (interquartile range, 1-2 days), 3.5 days (interquartile
range, 2-5 days), and 8 days (interquartile range, 3-9 days; P<.00001). The multivariate hazard ratio for early
extubation was 0.24 (95% confidence interval, 0.16-0.35) and 0.37 (95% confidence interval, 0.25-0.55) for the
intraoperative transfusion and postoperative transfusion only groups, respectively (P<.00001). In addition, the
cardiopulmonary time, body weight, need for reoperation, and hemoglobin during cardiopulmonary bypass af-
fected the length of mechanical ventilation. Similar results were obtained for the length of intensive care unit
stay. In the subgroup of transfused infants, the volume of packed red blood cells also independently affected
both the length of mechanical ventilation and the length of intensive care unit stay.
Conclusions: The incidence and volume of blood transfusion markedly affects postoperative morbidity in pe-
diatric cardiac surgery. These results, although obtained by retrospective analysis, might stimulate attending
physicians to establish stringent blood-sparing approaches in their institutions. (J Thorac Cardiovasc Surg
2013;146:537-42)Earn CME credits at
http://cme.ctsnetjournals.org
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The Journal of Thoracic and Cavolumes. Although we,1-3 and other groups,4-8 have
presented comprehensive blood-sparing approaches en-
compassing, among others, miniaturized CPB circuits and
stringent transfusion triggers, which allow for a reduction
of the transfused blood volume and, even, transfusion-free
surgery in a substantial number of infants, the potential
benefits of these approaches have not been sufficiently
documented. Although the general risks of blood transfu-
sion, such as infection, inflammation, and transfusion-
related lung injury, are well known, only a few studies
have investigated the risks of transfusion in infants. In crit-
ically ill, noncardiac surgery, pediatric patients, transfusion
was independently associated with increased morbidity and
mortality.9 More specifically, in the setting of pediatric car-
diac surgery, the accumulating evidence from the available
studies has suggested that the amount of blood transfusion
can increase postoperative morbidity, as assessed by the
rate of infection or the length of mechanical ventilation or
intensive care unit (ICU) or hospital stay.10-13 However,
none of these latter studies included a blood-sparing ap-
proach in which the effect of transfusion-free pediatric car-
diac surgery on postoperative morbidity could be evaluated.rdiovascular Surgery c Volume 146, Number 3 537
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
Hb ¼ hemoglobin
ICU ¼ intensive care unit
RACHS-1 ¼ risk adjustment in congenital heart
surgery
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DWe, therefore, collected postoperative morbidity and
mortality data from the 288 infants who were included in
our previous study of the effects of a comprehensive
blood-sparing approach on transfusion requirements
and risk factors for transfusion.3 The hypothesis that
transfusion-free surgery reduced postoperative morbidity,
as assessed by the length of mechanical ventilation and
length of ICU stay, was confirmed by multivariate analysis.
In addition, within the subgroup of transfused infants, the
effect of intraoperative versus only postoperative transfu-
sion and the transfused volume of packed red blood cells
on these outcome parameters was investigated.METHODS
Patients
The patient selection criteria and patient characteristics have been pre-
viously published.3 In brief, 288 infants with a body weight less than 16 kg
were included in the retrospective analysis. Most of these presented with
combined cardiac defects. Their median age was 161 days (range, 3 days
to 4.8 years), the median body weight was 5.8 kg (range, 1.7-15.9 kg).
Additional characteristics included a reoperation rate of 18%, potentially
cyanotic heart defects in 54%, and persisting cyanosis after palliative sur-
gery in 9%. All parents provided written informed consent for the surgical,
anesthesia, and monitoring procedures. The institutional review board of
our institution approved the retrospective data analysis.
CPB, Surgery, and Monitoring
Within the comprehensive blood-sparing approach described previ-
ously,3 body weight-adapted CPB circuits with a total priming volume of
95, 110, and 200 mL for infants with a body weight of less than 3, 3 to
5, and 5 to 16 kg, respectively, were used. Packed red blood cells were
added to the priming solution only when the estimated hemoglobin (Hb)
was<7.0 g/dL. The transfusion trigger during CPBwasHb<7.0 g/dL. Tra-
nexamic acid (10 mg/kg/h) was added for antifibrinolysis. Moderate hypo-
thermia was used, except for cases requiring deep hypothermic circulatory
arrest (n¼ 31), in which the temperaturewas decreased to 14 to 17C. The
decision for postoperative transfusion was determined by the attending
physicians. The major reasons for postoperative transfusion were low Hb
due to blood loss and hemodynamic instability. In addition to standard
hemodynamic and blood gas monitoring, near-infrared spectrometry
(NIRO-200, Hamamatsu Photonics KK, Hamamatsu City, Japan) was
used to monitor the cerebral and lower body tissue oxygenation.
Statistical Analysis
The patient characteristics and morbidity data were compared among
the groups by analysis of variance on ranks, followed by all pairwise mul-
tiple comparisons using Dunn’s method or the rank sum test, as appropri-
ate. The rates were assessed using the chi-square test. P values from all
pairwise multiple comparisons were adjusted according to the sequentially538 The Journal of Thoracic and Cardiovascular Surgrejective method of Holm. On univariate analysis, the effects of transfusion
on the length of mechanical ventilation and ICU stay were assessed using
Kaplan-Meier curves and log-rank tests. Multivariate analyses were ap-
plied to determine whether transfusion versus no transfusion or, within
the subgroup of transfused infants, the transfused volume of packed red
blood cells independently affected the morbidity parameters, length of me-
chanical ventilation and length of ICU stay (Cox regression proportional
hazardsmodel). Age and size and duration of surgery and aortic crossclamp
timewere excluded because of the substantial colinearity with body weight
and duration of CPB, respectively. See Tables 2 and 3 for a listing of all
covariates included in the analyses.RESULTS
As reported previously,3 surgery could be completed
without blood transfusion in 139 patients (48.3%); how-
ever, 68 of these patients received transfusion during
the postoperative period. Accordingly, the patients were
assigned to 3 different groups: no transfusion (n ¼ 71;
24.7%), postoperative transfusion only (n ¼ 68; 23.6%),
and intraoperative transfusion (n ¼ 149; 51.7%; with all
but 1 of these patients also receiving a postoperative trans-
fusion). The patient data according to these groups have
been reported in our previous study.3 In brief, intra- and
postoperative blood transfusion was related to body weight,
surgical complexity as reflected by the CPB time, the use of
deep hypothermic circulatory arrest, and, below the statisti-
cal threshold, palliative surgery with persisting cyanosis.
Patients requiring transfusion had significantly greater
risk adjustment in congenital heart surgery (RACHS-1)
scores: median RACHS-1 score, 2 (interquartile range,
1-3) for no transfusion group; 3 (interquartile range, 2-3)
for the postoperative transfusion only group; and 3 (inter-
quartile range, 2-4) for the intra- and postoperative transfu-
sion group (P < .00001; Table 1). The preoperative
coagulation parameters were similar among the 3 groups,
with the exception of lower antithrombin III concentrations
in the transfused groups. However, the postoperative fibrin-
ogen and platelet concentrations were lower in the
transfused groups (P<.00001; Table 1). The Hb concentra-
tions were similar among the 3 groups preoperatively, de-
creased similarly in all groups with the onset of CPB, and
increased toward the end of CPB and surgery. However,
this increase was markedly more pronounced in the group
of infants who received intraoperative transfusion. The post-
operative 48-hour blood loss was markedly greater in the
transfused groups and was also greater in the infants requir-
ing intraoperative transfusion compared with those requir-
ing only postoperative transfusion (P<.00001; Table 1).
The lengths of mechanical ventilation and ICU stay
were markedly different among the 3 groups. The median
length of mechanical ventilation was 11 hours (interquar-
tile range, 9-18 hours) in the no transfusion group, 33
hours (interquartile range, 18-80 hours) in the postopera-
tive transfusion only group, and 93 hours (interquartile
range, 34-161 hours) in the intraoperative transfusionery c September 2013
TABLE 1. RACHS-1 score, coagulation status, and postoperative blood loss
Variable No transfusion Postoperative transfusion Intraoperative transfusion P value
Patients (n) 71 (24.7) 68 (23.6) 149 (51.7)
RACHS-1 score 2 (1-3) 3 (2-3)* 3 (2-4)* <.00001
Prothrombin time (%) 90 (80-96) 86 (78-91) 86 (76-93) .24
INR 1.10 (1.03-1.19) 1.10 (1.07-1.20) 1.10 (1.05-1.20) .46
PTT (s) 36 (35-39) 37 (34-40) 36 (33-40) .97
AT III (%) 106 (95-114) 98 (86-105)* 88 (74-101)* <.00001
Fibrinogen (mg/dL)
Preoperative 268 (234-308) 257 (228-298) 263 (214-314) .73
Postoperative 181 (156-205) 139 (115-167)* 165 (142-191)*,y <.00001
Platelets (1000/mL)
Preoperative 358 (295-418) 364 (256-428) 364 (284-443) .70
Postoperative 234 (180-290) 201 (138-261)* 165 (117-211)* <.00001
48-h Blood loss (mL/kg) 17 (11-26) 25 (15-42)* 33 (23-52)*,y <.00001
PRBCs
Patients (n) 66 (97) 149 (100) —
Volume (mL/kg) 23 (19-30) 38 (26-67) <.00001
FFP 25 (37) 137 (92) <.00001
TC 2 (3) 48 (32) <.00001
Data presented as n (%) or median (interquartile range). Data on transfusion requirements have been published previously in the same journal (3). P values derived from analyses
of variance on ranks followed by Dunn’s post hoc tests or chi-square tests, as appropriate. RACHS-1, Risk adjustment in congenital heart surgery; INR, international normalized
ratio; PTT, partial thromboplastin time; AT III, antithrombin III; PRBCs, packed red blood cells; FFP, fresh frozen plasma; TC, thrombocyte concentrate. *P<.05 versus no
transfusion. yP<.05 versus postoperative transfusion only.
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Dgroup (P< .00001). Similarly, the length of ICU stay in-
creased from 1 day (interquartile range, 1-2 days) in the
no transfusion group to 3.5 days (interquartile range,
2.0-5.3 days) in the postoperative transfusion only group
and 6 days (interquartile range, 3-9 days) in the intraoper-
ative transfusion group (P<.00001). In-hospital mortality
was too low for detailed statistical analysis. However, noTABLE 2. Factors affecting length of mechanical ventilation*
Variable
HR for early
extubation 95% CI P value
Intraoperative transfusion 0.16 0.09-0.26 <.00001
Postoperative transfusion only 0.22 0.14-0.35 <.00001
RACHS-1 score>2 0.71 0.52-0.99 .04
CPB time (min) 0.997 0.994-0.999 .01
Body weight (kg) 1.12 1.04-1.19 .001
Reoperation 0.69 0.44-1.07 .10
DHCA 0.82 0.45-1.50 .52
Postoperative cyanosis 1.05 0.62-1.76 .86
Hb CPB (g/dL) 0.86 0.79-0.95 .002
BE CPB (mmol/L) 0.99 0.94-1.05 .71
rSO2 brain CPB (%) 1.00 0.99-1.01 1.00
rSO2 lower body CPB (%) 1.01 0.99-1.02 .26
Preoperative AT III 1.00 0.99-1.01 .77
Postoperative fibrinogen (mg/dL) 1.00 0.99-1.00 .92
Postoperative platelets (1000mL) 1.0022 1.0001-1.0043 .04
48-h Blood loss (mL/kg) 0.994 0.989-0.999 .03
HR, Hazard ratio; CI, confidence interval; DHCA, deep hypothermic circulatory
arrest; Hb CPB, hemoglobin concentration during stable conditions at mid-
cardiopulmonary bypass; BE, base excess; rSO2, regional oxygen saturation as
determined by near-infrared spectrometry; AT III, antithrombin III; RACHS-1, risk
adjustment in congenital heart surgery; CPB, cardiopulmonary bypass. *Multivariate
Cox regression proportional hazards model.
The Journal of Thoracic and Cainfant in the no transfusion group died compared with 1
child (1.5%) in the postoperative transfusion only group
and 9 (6.0%) in the intraoperative transfusion group
(overall P ¼ .04, chi-square test).
An analysis of the length of mechanical ventilation and
length of ICU stay by Kaplan-Meier curves and log-rankTABLE 3. Factors affecting length of ICU stay*
Variable
HR for early
release
from ICU 95% CI P value
Intraoperative transfusion 0.26 0.16-0.44 <.00001
Postoperative transfusion only 0.35 0.22-0.58 <.00001
RACHS-1 score>2 0.75 0.54-1.04 .09
CPB time (min) 0.998 0.995-1.001 .12
Body weight (kg) 1.05 0.98-1.12 .18
Reoperation 0.61 0.41-0.93 .02
DHCA 0.74 0.41-1.34 .32
Postoperative cyanosis 0.91 0.55-1.53 .73
Hb CPB (g/dL) 0.96 0.87-1.05 .35
BE CPB (mmol/L) 0.99 0.94-1.04 .71
rSO2 brain CPB (%) 1.00 0.99-1.01 .58
rSO2 lower body CPB (%) 1.00 0.99-1.02 .52
Preoperative AT III 1.00 0.99-1.01 .46
Postoperative fibrinogen (mg/dL) 1.00 0.99-1.00 .74
Postoperative platelets (1000/mL) 1.00 1.00-1.00 .85
48-h Blood loss (mL/kg) 0.994 0.990-0.999 .01
ICU, Intensive care unit; HR, hazard ratio; CI, confidence interval; RACHS-1, risk
adjustment in congenital heart surgery; CPB, cardiopulmonary bypass;
DHCA, deep hypothermic circulatory arrest; Hb CPB, hemoglobin concentration dur-
ing stable conditions at mid-cardiopulmonary bypass; BE, base excess; rSO2, regional
oxygen saturation as determined by near-infrared spectrometry;AT III, antithrombin III.
*Multivariate Cox regression proportional hazards model.
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FIGURE 1. Left, Length of mechanical ventilation and Right, length of intensive care unit stay analyzed by Kaplan-Meier curves for 3 groups of infants.
Differences among groups were assessed using log-rank tests, and P values were adjusted according to sequentially rejective method of Holm. All adjusted
P<.00001. ICU, Intensive care unit, OP, operative.
TABLE 4. Subgroup of transfused infants: volume of transfused
packed red blood cells*
Variable
HR for early
extubation and early
release from ICU 95% CI P value
Length of ventilation (h)
Intraoperative transfusion 0.81 0.55-1.19 .29
PRBC volume middle
tertile
0.56 0.38-0.82 .003
PRBC volume upper
tertile
0.20 0.12-0.34 <.00001
RACHS-1 score>2 0.62 0.43-0.91 .01
Blood loss (mL/kg) 0.994 0.989-0.999 .02
Postoperative platelets
(1000/mL)
1.003 1.001-1.005 .02
Length of ICU stay (d)
Intraoperative transfusion 0.98 0.67-1.44 .92
PRBC volume middle
tertile
0.58 0.39-0.85 .006
PRBC volume upper
tertile
0.30 0.19-0.49 <.00001
RACHS-1 score>2 0.67 0.45-0.99 .04
Blood loss (mL/kg) 0.994 0.990-0.999 .02
HR,Hazard ratio; ICU, intensive care unit;CI, confidence interval; PRBC, packed red
blood cell; RACHS-1, risk adjustment in congenital heart surgery. *Multivariate Cox
regression proportional hazards model applied to subgroup of transfused infants; all
covariates listed in Tables 2 and 3 were included in analyses, but only those that
significantly affected length of mechanical ventilation or length of ICU stay in this
subgroup are listed.
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Dtests (Figure 1) confirmed the differential negative effect of
postoperative transfusion only and intraoperative transfu-
sion on these outcome parameters. The results of the
multivariate analyses are listed in Tables 2 and 3. Both
intra- and postoperative transfusion were identified as
significant independent hazards for early extubation and
release from the ICU. In addition, the RACHS-1 score,
complexity of surgery (CPB time), low body weight,
high Hb during mid-CPB, postoperative platelet count,
and 48-hour postoperative blood loss negatively affected
early extubation (Table 2). The length of ICU stay was
also affected by the RACHS-1 score, reoperation rate,
and 48-hour blood loss (Table 3). Within the subgroups
of transfused infants, the volume of transfused packed
red blood cells, RACHS-1 score, and 48-hour blood loss
independently determined both the length of mechanical
ventilation and the length of the ICU stay (Table 4).
Thus, patients in the upper tertile of the transfused volume
were ventilated for 146 hours (interquartile range, 97-226
hours) compared with 58 hours (interquartile range,
29-97 hours) in the middle tertile and 29 hours (interquar-
tile range, 16-61 hours) in the lower tertile. The length of
ICU stay was 8 days (interquartile range, 5-13 days) in the
upper, 4 days (interquartile range, 3-7 days) in the middle,
and 3 days (interquartile range, 1-5 days) in the lower
tertile (P<.00001).
DISCUSSION
The major finding of the present study was that blood
transfusion independently worsened the in-hospital out-
come of pediatric cardiac surgery patients. Infants receiving540 The Journal of Thoracic and Cardiovascular Surgintraoperative blood transfusion presented with the longest
duration of mechanical ventilation and ICU stay, followed
by those with postoperative transfusion only. The groupery c September 2013
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Dwithout transfusion had the quickest recovery. Within the
subgroup of transfused children, the volume of transfused
packed red blood cells also independently affected the
lengths of ventilation and ICU stay.
The general risks of blood transfusion are well docu-
mented and include transmission of infectious agents,14 in-
flammatory responses,15,16 and transfusion-related acute
lung injury.17-19 However, only a few studies have
analyzed the effects of transfusion in the setting of
pediatric cardiac surgery. In a retrospective analysis, the
total volume of transfused blood products was associated
with an increased rate of infection.10 Also, the length of
mechanical ventilation was independently affected by intra-
operative transfusion11 or the volume per kilogram of peri-
operative transfusion of blood products.12 In another study,
only the postoperative volume of transfused blood products
was evaluated and was found to increase the duration of
mechanical ventilation and incidence of infection and acute
kidney injury.13 However, on the multivariate analyses, only
the length of hospital stay in the subgroup of biventricular
infants was independently associated with the need for
postoperative transfusion.
Our study has expanded on these findings by analyzing
the effects of blood transfusion on postoperative morbidity
in a large group of infants treated with a comprehensive
blood-sparing approach,3 in which nearly 25% of infants
received no transfusion at all, 24% received only postoper-
ative transfusion, and 52% required transfusion intraopera-
tively. The results seem to support our thought that
transfusion should be avoided when possible. Both intrao-
perative and, albeit to a lesser extent, postoperative transfu-
sion increased the lengths of ventilation and ICU stay. Some
of the covariates (ie, low body weight, long duration of
CPB, and need for reoperation) that increased the need
for transfusion in our previous study3 also increased the
length of mechanical ventilation and length of ICU stay,
raising the question of whether the observed effect of trans-
fusion merely reflected the effect of these covariates on our
outcome parameters. However, the multivariate analyses
confirmed that transfusion affected postoperative morbidity
independently of these covariates. When transfusion cannot
be avoided, it might be beneficial to transfuse only the min-
imal required volume, because even within the subgroup of
transfused infants, the volume of transfused blood
seemed to lengthen the duration of mechanical ventilation
and ICU stay, confirming previous results.12,13 Another
interesting finding within the subgroup of transfused
infants was the observation that intra- versus only
postoperative transfusion was associated with a longer
duration of mechanical ventilation independently of the
amount of transfused blood. It might be beneficial to
postpone transfusion until after completing CPB or to the
postoperative period in general, although this would
require confirmation from a prospective study.The Journal of Thoracic and CaAnunexpectedfindingwas that a greaterHbduring the sta-
ble conditions at mid-CPB was also associated with longer
lengths of ventilation and ICU stay. We believe that this
findingmight, at least in part, have resulted from the inclusion
of patients undergoing palliative surgery with persisting
cyanosis, such as in single ventricle infants.Although persist-
ing cyanosis was not independently associated with the
lengths of mechanical ventilation and ICU stay, these
patients presented with a greater Hb during CPB (median,
9.3 g/dL; interquartile range, 8.5-11.3; vs 8.2 g/dL; interquar-
tile range, 7.5-9.2; P<.00001), a longer duration of ventila-
tion (median, 60 hours; interquartile range, 26-187; vs
median, 40 hours; interquartile range, 14-104; P ¼ .03),
and longer ICU stay (median, 6 days; interquartile range,
3-12; vs median, 4 days; interquartile range, 1-7; P ¼ .02).
Study Limitations
The potential limitations of the present study were dis-
cussed in our previous report.3 These included the retro-
spective nature of our analyses,20 the lack of a universally
applicable lower limit for tolerable hematocrit or Hb levels
during CPB,8,21-24 and the lack of long-term outcome data
(ie, psychomotor development of the infants). The major
limitation, however, was that the multivariate analyses
might not have been sufficiently adjusted for group assign-
ment bias, meaning that the same covariates that determined
the need for transfusion might have also determined the
need for longer mechanical ventilation and ICU stays. In
the present study, coagulation disorders (preoperative or
occurring during surgery) leading to increased blood loss
and the severity of the underlying cardiac malformations
might have affected both the need for transfusion and post-
operative morbidity. We tried to adjust for this by including
the laboratory data for coagulatory function, postoperative
blood loss, RACHS-1 score, duration of surgery, need for
reoperation, and palliative surgery with persisting cyanosis
in the multivariate analyses. In addition, the multivariate
analyses were repeated for the subgroups of patients with
lower or higher RACHS-1 scores and after excluding all
infants with persisting cyanosis. In all these analyses,
transfusion was confirmed as a highly significant
(P<.001 to P<.00001) independent predictor of the length
of mechanical ventilation and ICU stay (data not shown).
CONCLUSIONS
We have demonstrated that within a comprehensive
blood-sparing approach, intraoperative transfusion and, to
a lesser extent, postoperative transfusion only indepen-
dently increased the postoperative morbidity, as determined
by the length of mechanical ventilation and length of ICU
stay in pediatric cardiac surgery patients. Similar results
were found for the amount of transfused blood within the
subgroup of transfused infants. Although additional, pro-
spective studies on this issue are needed, the accumulatingrdiovascular Surgery c Volume 146, Number 3 541
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Devidence of the present study, and previous studies, of
the detrimental effects of blood transfusion in the setting
of pediatric cardiac surgery should encourage surgeons,
anesthetists, and perfusionists in charge of these infants to
unite their efforts to establish blood-sparing procedures at
their institutions. We believe that miniaturization of the
CPB circuits, as described previously,1-3 should be a key
component of such a comprehensive approach.
This study would not have been possible without the invaluable
contribution of Argid and Raimund Rutenberg, who took great ef-
forts to carefully collect and organize the data from the different
databases in our institution.
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